For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220714:nRSN5154Sa&default-theme=true
RNS Number : 5154S Dr. Martens PLC 14 July 2022
14 July 2022
DR. MARTENS PLC
RESULT OF ANNUAL GENERAL MEETING
14 JULY 2022
The Company announces the results of voting at its Annual General Meeting held
earlier today and confirms that all resolutions were duly passed on a poll
with majorities as set out below.
Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16
to 19 as Special Resolutions.
Resolution Votes % Votes Against % Votes Votes Withheld % Voting
For
Total
Capital Instructed
01 Receive the 2022 Annual Report and Accounts 813,848,188 100.00 0 0.00 813,848,188 783,563 81.36%
02 Approve the Directors' Remuneration Report 807,707,382 99.15 6,923,259 0.85 814,630,641 1,110 81.44%
03 Approve the Final Dividend 811,746,252 99.65 2,885,099 0.35 814,631,351 400 81.44%
04 Re-elect Paul Mason 798,851,082 98.70 10,553,833 1.30 809,404,915 5,226,836 80.92%
05 Re-elect Kenny Wilson 809,826,477 99.41 4,804,764 0.59 814,631,241 510 81.44%
06 Re-elect Jon Mortimore 809,094,165 99.32 5,537,076 0.68 814,631,241 510 81.44%
07 Re-elect Ian Rogers 810,551,309 99.50 4,079,932 0.50 814,631,241 510 81.44%
08 Re-elect Ije Nwokorie 809,887,078 99.42 4,744,163 0.58 814,631,241 510 81.44%
09 Re-elect Lynne Weedall 791,704,376 97.19 22,926,665 2.81 814,631,041 710 81.44%
10 Re-elect Robyn Perriss 803,176,287 98.59 11,454,954 1.41 814,631,241 510 81.44%
11 Re-elect Tara Alhadeff 804,121,618 98.71 10,509,623 1.29 814,631,241 510 81.44%
12 Appoint PricewaterhouseCoopers LLP as auditor 813,775,770 99.89 855,681 0.11 814,631,451 300 81.44%
13 Authorise the Audit & Risk Committee to determine the Auditor's 814,220,813 99.95 410,638 0.05 814,631,451 300 81.44%
remuneration
14 Authorise the Company and its subsidiaries to make political donations 809,153,872 99.33 5,476,763 0.67 814,630,635 1,116 81.44%
15 Authorise allotment of shares 797,319,899 97.87 17,311,344 2.13 814,631,243 508 81.44%
16 Authorise general disapplication of pre-emption rights* 813,947,595 99.92 683,756 0.08 814,631,351 400 81.44%
17 Authorise additional disapplication of pre-emption rights* 811,886,184 99.66 2,745,167 0.34 814,631,351 400 81.44%
18 Authorise purchase of own shares* 813,899,052 99.95 446,465 0.05 814,345,517 286,234 81.41%
19 Authorise calling of general meetings on 14 days' notice* 795,268,484 97.62 19,362,867 2.38 814,631,351 400 81.44%
*Special Resolution
The votes of independent shareholders on the resolutions concerning the
election or re-election of the Independent Non-Executive Directors are set out
below:
Resolution Votes % Votes Against % Votes Votes Withheld % Independent
For
Total
Capital Instructed
07 Re-elect Ian Rogers 440,608,869 99.08 4,079,932 0.92 444,688,801 510 70.55%
08 Re-elect Ije Nwokorie 439,944,638 98.93 4,744,163 1.07 444,688,801 510 70.55%
09 Re-elect Lynne Weedall 421,761,936 94.84 22,926,665 5.16 444,688,601 710 70.55%
10 Re-elect Robyn Perriss 433,233,847 97.42 11,454,954 2.58 444,688,801 510 70.55%
Notes:
1. Votes "For" and "Against" are expressed as a percentage of votes received.
2. A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.
3. As at 6.30pm on 12 July 2022 the Company had a total of 1,000,283,652
ordinary shares with voting rights in issue. The total independent voting
capital, used to calculate the votes of independent shareholders on
resolutions 7-10, was 630,341,212.
4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as
special business will shortly be available for inspection on the National
Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
Enquiries
Investors and analysts
Mark Blythman, Interim Director of Investor Relations
+44 7570 871207
mark.blythman@drmartens.com (mailto:mark.blythman@drmartens.com)
Media
Gill Hammond, Director of
Communications +44 7384
214248
Maitland
+44 20 7379 5151
Clinton Manning +44
7711 972 662
Joanna Davidson +44
7827 254 567
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Originally produced for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while
still celebrating their proud heritage and, six decades later, "Docs" or "DMs"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude.
The Company successfully listed on the main market of the London Stock
Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250
index.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGGPUPWMUPPGGC